Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Sorafenib 29 Nivolumab 15 pembrolizumab 12 Radiosurgery 9 Bevacizumab 9 atezolizumab 7 regorafenib 5 Radiotherapy 5 Fluorouracil 5 Doxorubicin 5 lenvatinib 4 Sunitinib 4 Oxaliplatin 4 Ipilimumab 4 Gemcitabine 4 Ethiodized Oil 4 Erlotinib Hydrochloride 4 Capecitabine 4 TLC 388 3 Radiofrequency Ablation 3 Leucovorin 3 Everolimus 3 Cisplatin 3 Blood Specimen Collection 3 toripalimab 2 phosphomannopentaose sulfate 2 durvalumab 2 cediranib 2 avelumab 2 Tirapazamine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Hepatocellular × Artesunate × Clear all

NCT02304289 2021-10-27

DESPARTH

University Hospital, Ghent

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡